Close
Triumph Motorcycle Dealers Ranked First in Industry Study for Providing Quick and Easy Service Appointments Jun 3, 2024 12:01AM
  • Industrywide 1 in 7 Powersports Customers Failed in their Attempt to Schedule Service

MONTEREY, Calif.--(BUSINESS WIRE)-- Triumph was ranked first of 27 powersports brands in Pied Piper’s 2024 PSI® Service Telephone Effectiveness® (STE®) Study, which measured the efficiency and quality of service telephone calls from a customer’s objective of quickly and easily setting up a service appointment. Following the Triumph dealers in the rankings were dealers... (continue reading...)


Appointment of Director to Woodside Board Jun 2, 2024 10:51PM

PERTH, Australia--(BUSINESS WIRE)-- The Woodside Board is pleased to announce the appointment of Mr Anthony (Tony) O’Neill as a nonexecutive Director, effective 3 June 2024.

“We continually review our Board composition to ensure that Woodside’s Board is best placed to support Woodside’s global operations and strategic growth opportunities. Tony O’Neill has a distinguished reputation for his transformational work in the global mining industry and has... (continue reading...)


Nissan Demonstrates Autonomous-Drive Mobility Services Progress on Public Roads Jun 2, 2024 09:00PM

YOKOHAMA, Japan--(BUSINESS WIRE)-- Nissan has commenced demonstrations of a prototype vehicle equipped with its in-house-developed, autonomous drive technologies - showcasing progress in its goal towards rolling out autonomous mobility services within fiscal year 2027.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240602021801/en/

(Photo: Business Wire)

The Nissan LEAF prototype vehicle incorporates 14... (continue reading...)


WEBTOON Entertainment Announces Public Filing of Registration Statement for Proposed Initial Public Offering Jun 2, 2024 08:35PM

LOS ANGELES--(BUSINESS WIRE)-- WEBTOON Entertainment Inc. (“WEBTOON” or “the Company”), a leading global entertainment company and home to some of the world’s largest storytelling platforms, today announced that it publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) on Friday, May 31, 2024, relating to a proposed initial public offering of its common stock.

The number of shares to be offered... (continue reading...)


Other World Computing Introduces Intel Thunderbolt Share for the Thunderbolt Go Dock Jun 2, 2024 07:00PM

Exciting New Application from Intel Enables Fast PC-to-PC Connectivity

TAIPEI, Taiwan--(BUSINESS WIRE)-- Other World Computing – the leading solution provider of computer hardware, accessories, and software that bring artistic expression and the digital world together for creative professionals and consumers of technology – today announced at the COMPUTEX tradeshow, a collaboration with Intel® Thunderbolt™ Share to provide fast PC-to-PC experiences via the... (continue reading...)


More Business Wire

View Older Stories

Jun 2, 2024 06:00PM New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse
Jun 2, 2024 02:32PM TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
Jun 2, 2024 12:30PM CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated
Jun 2, 2024 10:56AM Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
Jun 2, 2024 10:01AM Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
Jun 2, 2024 09:30AM Tempus Introduces New HER2 & FOLR1 Testing Solutions to Support Personalized Patient Care
Jun 2, 2024 09:00AM ZT Systems Announces ACX200 Solutions Featuring NVIDIA GB200 Grace Blackwell Superchips for Next-Generation Accelerated Computing
Jun 2, 2024 08:30AM Denodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
Jun 2, 2024 08:30AM Denodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises
Jun 2, 2024 08:05AM IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo
Jun 2, 2024 08:00AM ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
Jun 2, 2024 08:00AM ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lin
Jun 2, 2024 08:00AM Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the Unit
Jun 2, 2024 08:00AM Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
Jun 2, 2024 07:00AM June Joy at Juicy Stakes Casino
Jun 1, 2024 02:25PM New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
Jun 1, 2024 02:20PM Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
Jun 1, 2024 10:00AM First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024
Jun 1, 2024 10:00AM "Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
Jun 1, 2024 09:30AM Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
Jun 1, 2024 09:15AM Postmedia Announces Closing of Previously Announced Transaction with the Klein Group
Jun 1, 2024 09:00AM Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community
Jun 1, 2024 09:00AM Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
Jun 1, 2024 08:10AM Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual
Jun 1, 2024 08:00AM Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
Jun 1, 2024 08:00AM Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
Jun 1, 2024 08:00AM KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Canc
Jun 1, 2024 08:00AM Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Jun 1, 2024 08:00AM Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
Jun 1, 2024 08:00AM Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
Jun 1, 2024 08:00AM Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Jun 1, 2024 02:43AM Clariane: Information on the Availability of an Amendment to the 2023 Universal Registration Document
May 31, 2024 11:13PM AnalytixInsight Reports 2023 Financial Results and Provides MCTO Status Update
May 31, 2024 10:02PM The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe Regional Drought
May 31, 2024 08:55PM Generation Mining Files Final Base Shelf Prospectus and Updates Shareholders
May 31, 2024 08:27PM Tikehau Capital: Disclosure of shares repurchases from 24 May 2024 to 30 May 2024
May 31, 2024 07:52PM Government Regulation Creates Blue Oceans
May 31, 2024 07:43PM Inocras Presents Poster for Breast Cancer at 2024 ASCO Annual Meeting, Showing Transformative Impact of WGS-based HRD Testing
May 31, 2024 07:39PM Leading Independent Proxy Advisory Firm Institutional Shareholder Services Joins Glass Lewis in Recommending Votes “FOR” ALL Nine WisdomTree Board Nominees
May 31, 2024 07:30PM BRW Announces Notification of Sources of Distributions
May 31, 2024 07:30PM SABA Announces Notification of Sources of Distributions
May 31, 2024 07:00PM  Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Che
May 31, 2024 06:29PM FCPT Announces Acquisition of a Mavis Tire Property for $2.4 Million
May 31, 2024 06:27PM University of Phoenix and Executive Networks Study on Workplace Well-Being Highlights Challenges of Current Approaches in Addressing Mental Health
May 31, 2024 06:00PM Capstone Copper Announces Retirement of Robert Gallagher from the Board of Directors
May 31, 2024 06:00PM Drive Shack Inc. Releases Fourth Quarter and Full-Year 2023 Financial Results
May 31, 2024 05:55PM Medical Properties Trust Publishes Its Third Annual Corporate Responsibility Report
May 31, 2024 05:49PM FCPT Announces Acquisition of a National Veterinary Associates Property for $2.0 Million
May 31, 2024 05:49PM Fonon's Additive Manufacturing Technology To Transform Construction Industry
May 31, 2024 05:45PM Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View Older Stories